Skip to content
Aerpio Pharmaceuticals
  • Contact Us
  • Careers
  • About Aerpio
    • Management
    • Board of Directors
    • Scientific Advisory Board
    • Ophthalmology Advisory Boards
    • Aerpio COVID-19 Steering Committee
  • Technology
    • Tie2 Pathway – The Basics
    • VE-PTP and Angpt2
    • Aerpio’s Tie2 Activators
  • Pipeline
    • Razuprotafib (AKB-9778) Open Angle Glaucoma
    • Razuprotafib COVID-19/ARDS
    • Razuprotafib (AKB-9778) Diabetic Nephropathy
    • ARP-1536 Retinopathy/Nephropathy
    • Bispecific Ab Retinopathy/Cancer
    • GB004/AKB-4924 IBD
  • Therapeutic Areas
    • Open Angle Glaucoma
    • COVID-19/ARDS
    • Diabetic Nephropathy
    • Retinopathy (Wet AMD/DME)
    • Cancer
    • IBD
  • Partnering
  • Investors
  • Publications
Aerpio Pharmaceuticals
Home > About Aerpio > Management
  • Share
    •  
    •  
  • Print

Management

Management

Joseph Gardner

PhD - President and Founder

Read More

Kevin Peters

MD - Chief Scientific Officer and Chief Medical Officer

Read More

Mitchell Brigell

PhD - Consultant – VP Clinical

Read More

Brandi Soldo

PhD, DABT – Vice-President, Toxicology

Read More

Gina Marek

CPA, MBA – Vice-President, Finance

Read More

Barb Withers

PhD- Vice President, Clinical Operations

Read More

Chris Ernst

BS – Vice President, CMC and Quality Assurance

Read More

  • About Aerpio
    • Management
    • Board of Directors
    • Scientific Advisory Board
    • Ophthalmology Advisory Boards
    • Aerpio COVID-19 Steering Committee

© Aerpio

  • Terms of Use
  • Privacy Policy
Website by Axxiem
close ×